This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Complementary Medicine -
Antispermatogenic activity of Morinda lucida extract in male rats
Yinusa Raji1, Olumide S. Akinsomisoye2, Toyin M. Salman1
1Department of Physiology, College of Medicine, University of Ibadan,Ibadan, Nigeria
2Department of Physiological Sciences, Faculty of Basic Medical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
Abstract
Aim: To investigate the effect of Morinda
lucida Benth (Rubiaceae) on the reproductive activity of male albino rats.
Methods: Two groups of rats were treated with 400 mg/(kg·d) of
Morinda lucida leaf extract for 4 and 13 weeks,
respectively. The control rats received the vehicle. All the treated rats had corresponding recovery groups. At the end
of each experimental period, animals were killed and organ weights, sperm characteristics, serum testosterone levels,
histology of the testes and fertility were assessed.
Results: Morinda lucida leaf extract did not cause any changes in
body and somatic organ weights, but significantly increased the testis weight
(P < 0.05). The sperm motility and viability, and the epididymal sperm counts of rats treated for 13 weeks were significantly reduced
(P < 0.05). Sperm morphological abnormalities and serum testosterone levels were significantly increased
(P < 0.05). There were various degrees of damage to the seminiferous tubules. The extract reduced the fertility of the treated rats by
reducing the litter size. Reversal of these changes, however, occurred after a period of time.
Conclusion: The extract of Morinda
lucida has reversible antispermatogenic properties.
(Asian J Androl 2005 Dec; 7: 405-410)
Keywords: Morinda lucida; sperm; fertility; testosterone; antispermatogenic agents
Correspondence to: Dr Yinusa Raji, Department of Physiology,
College of Medicine, University of Ibadan, Ibadan, Nigeria.
Tel: +234-802-326-3626
E-mail: raji-ui@yahoo.com
Received 2004-09-01 Accepted 2005-03-21
DOI: 10.1111/j.1745-7262.2005.00051.x
1 Introduction
Morinda lucida Benth (Rubiaceae) is a medium-sized
tree about 15 m tall and is widely used as a medicinal
plant in West Africa, especially in Nigeria. The leaves
are used as an ingredient of "fever teas", which are
usually taken for the traditional treatment of malaria. The
plant is also used as a general febrifuge, analgesic and
laxative. A weak decoction of the stem bark is used for
the treatment of severe jaundice [1]. The major
constituents of Morinda lucida extract are various types of
alkaloids-anthraquinones and anthraquinols. Adewunmi
and Adesogan [2] isolated and characterized two
compounds , oruwalol and oruwal, and ten anthraquinones
from the stem of the plant.
Anthraquinones isolated from Morinda
lucida have shown to possess potent in
vitro activity against Plasmodium
falciparum [3]. Trypanocidal activity of the methanol extract of the leaf of this plant was reported by
Asuzu and Chineme [4]. Obih et al. [5] reported the
antimalarial activity of Morinda lucida against
Plasmodium berghei berghei in mice. Many antimalarial agents
have been demonstrated to have various degrees of
antifertility activities [6, 7]. The use of Morinda
lucida extracts in the treatment of various ailments is increasing,
but its impacts on the reproductive system have not been
reported. The present study was to investigate the
effects of Morinda lucida leaf extract on male rat
reproductive functions, such as sperm characteristics,
fertility and testosterone secretion.
2 Materials and methods
2.1 Plant material and extraction procedure
The leaves of Morinda lucida were obtained in March
2002 from a tree beside the Pharmacognosy Laboratory,
University of Ibadan. The plant specimen was
authenticated at the herbarium of the Forestry Research Institute
of Nigeria. The leaves were air-dried and then grounded
into powder that was subjected to Soxhlet cold
extraction using methanol as the solvent.
2.2 Animals
Adult male Wistar strain albino rats (200 g-300 g),
purchased from the Central Animal House, College of
Medicine, University of Ibadan, were used for the study.
The animals were housed in wire mesh cages under
standard environmental conditions with the provision of 12 h
light and 12 h darkness. Rat cubes (Ladokun feeds, Nig.
Ltd., Ibadan, Nigeria) and water were provided ad libitum.
2.3 Experimental protocol
A total of 30 male albino rats were divided into six
groups of five rats each with two treated, two recovery
and two control groups. The two treated groups received intragastric (i.g.) administration of 400 mg/(kg·d)
for 4 and 13 weeks, respectively. The corresponding
recovery groups were also treated for 4 and 13 weeks
and allowed to recover for 4 and 13 weeks, respectively.
The choice of duration of extract administration for
4 weeks was to mimic the use of the plant in traditional
treatment of malaria while that of 13 weeks was intended
to cover the spermatogenic cycles in rats. The control
groups received the equivalent volume of the vehicle
(Tween 80 in equivalent amount of normal saline). The
animals were weighed daily throughout the duration of
the study.
2.4 Autopsy and organ weights
At the end of the treatment and recovery periods,
each rat was anesthetized with 25 % urethane at a dose
of 0.6 mL/100 g (intraperitoneally, i.p.). The testes,
seminal vesicles and epididymis were dissected and weighed
immediately.
2.5 Blood sample collection
Blood was collected from each rat via the left
ventricular cardiac puncture. Serum for the estimation of
testosterone levels was obtained from the blood.
2.6 Sperm characteristic analysis
The testes from each rat were carefully exposed and
one of them was removed together with its epididymis.
The epididymis was separated and the epididymal fluid
was collected from the caudal part. The progressive
sperm motility, sperm count, live/dead ratio (viability)
and morphology were determined [8, 9].
2.7 Testicular histology
The testes of the rats were prefixed in Bouin-Hollande
solution prior to the histologic studies as earlier described
[6, 10].
2.8 Hormone assay
Serum testosterone assay was carried out using the
tube-based enzyme immunoassay (EIA) method [11]. This is a standardized method used by WHO and part of
its program for human reproduction research. The EIA
testosterone kits were produced by Immunometrics (London, UK) and obtained from Nzemat (Lagos,
Nigeria). The procedures for the assay as contained in
the manufacturer¡¯s manual were strictly followed. The
within assay variation was 8.1 % and the sensitivity was
0.3 ng/mL. The optical density was read using a
spectrophotometer (Jenway, 6300 spectrophotometer, UK)
that was sensitive at wavelengths between 492 nm and
550 nm.
2.9 Fertility test
Treated male rats were cohabited with untreated
parous proestrus female albino rats at a ratio of 1:2.
Cohabitation commenced on the first day of the last week
of extract treatment and the first day of the last week of
the recovery period. A single time point fertility test for
each rat was carried out using the following formula:
percentage fertility success is equal to the number of
pregnant females divided by the number of mated females multiplied by 100. The litter size of the pregnant
rats was also determined at the end of the gestation period.
2.10 Statistical analysis
Data were expressed as mean ± SEM. Statistical
significance between the various groups was determined
using unpaired t-test and ANOVA [12].
3 Results
3.1 Effect on body and organ weight of male rats
There were no significant changes in the body weight
of treated rats compared with the controls after 4 and
13 weeks of treatment. The recovery group also showed
an insignificant change in body weight compared with
their control counterpart. Administration of 400
mg/(kg·d) of the extract to the rats for 4 and 13 weeks increased
their testicular weights compared with the controls
(Table 1). There were also no significant changes in the
mean weight of the seminal vesicles in the treated groups
(Table 1).
3.2 Effect on spermatozoal indices
The effects on sperm motility, counts, viability and
morphology were shown in Table 2.
3.2.1 Motility
Oral administration of Morinda lucida leaf extract
for 4 and 13 weeks, progressively and significantly
reduced (P < 0.05) sperm progressive motility. There was
also a significant decrease (P < 0.05) in percentage sperm
motility in the recovery groups compared with the
respective control groups (Table 2).
3.2.2 Epididymal sperm count
Daily administration of the extract for 13 weeks
significantly reduced (P < 0.01) the mean epididymal sperm
counts compared with their controls and the recovery
groups, which showed an insignificant increase.
3.2.3 Viability (live/dead ratio)
There was a significant decrease (P < 0.05) in the
mean percentage of live sperm of rats treated with the
extract compared with their control counterparts. The
mean percentage of live sperm of rats in the 4-week
recovery group showed a significant reduction
(P < 0.05).
3.2.4 Morphology
The commonest morphological abnormality of sperm
in rats that received the extract for 4 and 13 weeks was
the "curved tail" which accounted for over 70 % of the
abnormalities observed. Although the recovery groups
showed a lesser occurrence of morphological
abnormali-ties, the increase in abnormalities were significantly higher
(P < 0.05) than those in the controls.
3.2.5 Serum testosterone levels
The mean serum testosterone level of rats treated
with 400 mg/(kg·d) of the extract for 4 and 13 weeks
significantly increased (P < 0.01) compared with the
controls (Figure 1).
3.2.6 Histologic evaluation
Administration of 400 mg/(kg·d) of the extract for 4
and 13 weeks caused visible lesions within the
seminiferous tubules compared with the controls
(Figure 2). There was degeneration and disorganization of the
plasmalemma in the basal portion of some of the seminiferous
tubules. However, regenerative changes were observed
in the recovery group.
3.2.7 Fertility tests
The fertility of the treated rats in terms of
percentage mated female rats was unaffected. However, the
fertility of these rats was significantly affected by the
extract treatments in terms of the number of litters born
by the cohabited female rats. Female rats cohabited with
treated male rats bore significantly reduced
(P < 0.05) number of litters: 6.20 ± 0.32 and 4.00 ± 0.27 for 4 and
13 weeks, respectively (control: 9.40 ± 0.44).
4 Discussion
Chronic administration of Morinda lucida leaf
extract could impair reproductive activities in male albino
rats. The extract caused an increase in the weight of the
testes, which was accompanied by an increase in the
serum levels of testosterone. Similar changes have been
reported with the extract of Zingiber
officinale and Pentadiplendra brazzeana in rats [13, 14]. Others have
reported testicular weight reduction accompanied by
decreased serum testosterone levels in male rats treated with
the extracts of Quassia amara [7], Azadirachta
indica [6] and gossypol, a phenolic compound extracted from the
cotton seed [15]. Both Quassia amara and
Azadirachta indica have been demonstrated to possess potent
antimalarial properties [6, 7]. Since all organs of male
reproduction are androgen dependent, they serve as
indicators of the Leydig cell function or androgen action
[16].
Testosterone in association with follicle stimulating
hormone normally acts on the seminiferous tubules to
initiate and maintain spermatogenesis [16]. However, a
significant decrease in the epididymal sperm count of
rats treated with the extract for 13 weeks was recorded
despite the high serum testosterone level. This was
supported by the various degrees of degeneration in the
histologic sections of the testes, suggesting that
Morinda lucida extract administration for a long period was
capable of permeating the blood-testis barrier [17]. This
probably led to tubular fluid retention, hence
non-restoration of testicular weights during recovery. The
appreciable increase in the epididymal sperm counts of rats in
the recovery groups suggests that the extract could be
responsible for the observed decrease in the first instance.
This was further corroborated by the fact that no
primary abnormalities were recorded in sperm
morphology, which normally occurs during the process of
spermatogenesis.
Reduction in the progressive epididymal sperm
motility of the treated rats could be responsible for the
decrease in the average number of litters born by the
female rats cohabited with the extract treated male rats
leading to the suspicion for the presence of a spermatoxic
agent on maturing or mature spermatozoa [18] in the
extract. Sperm motility depends on the coordinated
propagated flagella wave under acetyl cholinesterase
control [19]. Fructose utilization and glucose oxidation are
important means by which spermatozoa derive energy
for their motility. Morinda lucida has been shown to
possess hypoglycemic and anti-hyperglycemic activities
[20]. The reduction in motility recorded in this study
could be due to the acetylcholinesterase inhibition and
glucose lowering properties of this plant. The
progressive motility improved in the recovery groups,
suggesting that the deleterious effect was reversible.
Phytochemical analyses revealed that Morinda
lucida contains various types of anthraquinones and
anthranquinols [2]. Koumaglo et al. [3] and Sittie
et al. [21] reported the strong activity of anthraquinones
isolated from Morinda lucida against the growth of
Plasmodium falciparum. Furthermore anthraquinones
isolated from Morinda lucida extract have been reported to
possess potent activities against the growth of the
chloroquine resistant Plasmodium falciparum. Since several
studies have reported antifertility effects of antimalarial
agents including chloroquine, the antifertility activities
exhibited by Morinda lucida in this study could be
associated with anthraquinones presented in the extract.
Further studies aimed at elucidating the activities of
Morinda lucida extract would be worthwhile.
Acknowledgment
This work was partly supported by the University of
Ibadan Senate Research grants
SRG/COM/2000/11A to Yinusa Raji and we would, therefore, like to express our
gratitude to the University.
References
1 Oliver-Bever B. Medicinal Plants in Tropical West Africa.
Cambridge: Cambridge University Press; 1986. p89-90.
2 Adewunmi CO, Adesogan EK. Anthraquinones and oruwacin
from Morinda lucida as possible agents in
fasciolasis and schistosomiasis control. Fitoterapia 1984; 55: 259-63.
3 Koumaglo K, Gbeassor M, Nikabu O, de Souza C, Werner W.
Effects of three compounds extracted from Morinda
lucida on Plasmodium falciparum. Planta Med 1992; 58: 533-4.
4 Asuzu IU, Chineme CN. Effects of Morinda
lucida leaf extract on Trypanosoma brucei
brucei infection in mice. J
Ethnopharmacol 1990; 30: 307-31.
5 Obih PO, Makinde JM, Laoye JO: Investigations of various
extracts of Morinda lucida for antimalaraial actions on
Plasmodium berghei berghei in mice. Afr J Med Med Sci 1985;
14: 45-9.
6 Raji Y, Udoh US, Mewoyeka OO, Ononye FC, Bolarinwa
AF. Implication of reproductive endocrine malfunction in
male antifertility efficacy of Azadirachta
indica extract in rats. Afr J Med Med Sci 2003; 32: 159-65.
7 Raji Y, Bolarinwa AF. Antifertility activity of
Quassia amara in male rats - in vivo study. Life Sci 1997; 64: 1067-74.
8 World Health Organization. WHO Laboratory Manual for
Examination of Human Semen and Semen-Cervical Mucus
Interaction, 2nd ed. London: Cambridge University Press;
1987. p1-10.
9 Blom E. The ultrastructure of some characteristic sperm
defects and a proposal for a new classification of the bull
spermiogram. Mord Vet Med 1973; 25: 283-5.
10 Akpantah AO, Oremosu AA, Ajala MO, Noronha CC,
Okanlawon AO. The effects of crude extract of Garcinia
kola seed on the histology and hormonal milieu of male
Sprague-Dawley rats' reproductive organs. Nig J Health & Biomed Sci
2003; 2: 40-6.
11 Raji Y, Ifabunmi SO, Akinsomisoye OS, Morakinyo AO, Oloyo
AK. Gonadal responses to antipsychotic drugs: Chlopromazine
and thioridazine reversibly suppress testicular functions in
albino rats. Intl J Pharmacol 2005; 1: 287-92.
12 Snedecor GW, Cochran WG. Statistical Method, 7th edn.
Iowa: Iowa State University Press; 1980. p215.
13 Kamtchouing P, Mbongue Fandio GY, Dimo T, Jatsa HB.
Evaluation of androgenic activity of Zingiber
officinale and Pentadiplandra brazzeana in male rats. Asian J Androl 2002;
4: 299-301.
14 Watcho P, Kamtchouing P, Sokeng SD, Moundipa PF, Tantchou
J, Essame JL, Koueta N. Androgenic effect of Modia
whitei roots in male rats. Asian J Androl 2004; 6: 269-72.
15 Qian SZ, Wang ZG. Gossypol: a potential antifertility agent
for males. Annu Rev Pharmacol Toxicol 1984;24: 329-60.
16 Rommerts FF. How much androgen is required for
maintenance of spermatogenesis? J Endocrinol 1988; 116: 7-9.
17 Baldessarini RJ. Drugs and the treatment of psychiatric
disorders: the pharmacological basis of psychiatric disorders.
In: Goodman LS, Limbird LE, Milinoff PB, Ruddon RW,
Gilman AG, editors. Alfred Goodman and Gilman, The
Pharmacological Basis of Therapeutics. 6th ed. New York:
Mac-Millian; 1980. p301-417.
18 Verma RJ, Chinoy NJ. Effect of papaya seed extract on
microenvironment of cauda epididymis. Asian J Androl 2001; 3:
143-6.
19 Nelson L. Quantitative evaluation of sperm motility control
mechanisms. Biol Reprod 1972; 6: 319-24.
20 Olajide OA, Awe SO, Makinde JM, Morebise O. Evaluation
of the anti-diabetic property of Morinda
lucida leaves in streptozotocin-diabetic rats. J Pharm Pharmacol 1999; 51:
1321-4.
21 Sittie AA, Lemmich E, Hviid L, Kharazmi A, Nkrumah FK, Christensen SB. Structure-activity studies: in
vitro antilei-shmanial and antimalarial activities of anthraquinones from
Morinda lucida. Planta Med 1999; 65: 259-61.
|